• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三例丙戊酸钠治疗下的分娩——丙戊酸钠的胎盘转运、乳汁转运及可能的致畸性。

Three cases of delivery under sodium valproate--placental transfer, milk transfer and probable teratogenicity of sodium valproate.

作者信息

Tsuru N, Maeda T, Tsuruoka M

机构信息

Department of Psychiatry, Miyazaki Medical College.

出版信息

Jpn J Psychiatry Neurol. 1988 Mar;42(1):89-96. doi: 10.1111/j.1440-1819.1988.tb01960.x.

DOI:10.1111/j.1440-1819.1988.tb01960.x
PMID:3135429
Abstract

Here is a report of three cases of delivery from women who have taken sodium valproate (VPA). One neonate was born with polydactylism, and we reviewed the congenital malformations in children of mothers who have taken VPA. In the other two cases, we also examined the levels of VPA in the cord serum and breast milk. The levels of VPA in the cord serum were 50 micrograms/ml at 12 hours after the last maternal dose and 75 micrograms/ml at 14 hours after the last maternal dose. The blood levels of VPA in the two mothers were 48-59 micrograms/ml and 55-85 micrograms/ml in their late pregnancy, respectively. The levels of VPA in the breast milk were 2.0-3.5 micrograms/ml and the ratio of VPA in the breast milk to blood was 2-3%. These results suggest the high rate of placental transfer and the low rate of milk transfer of VPA.

摘要

以下是三例服用丙戊酸钠(VPA)的女性分娩情况报告。一名新生儿出生时患有多指畸形,我们回顾了服用VPA的母亲所生子女的先天性畸形情况。在另外两例中,我们还检测了脐血血清和母乳中VPA的水平。最后一剂母体用药后12小时,脐血血清中VPA水平为50微克/毫升,最后一剂母体用药后14小时为75微克/毫升。两名母亲在妊娠晚期血液中VPA水平分别为48 - 59微克/毫升和55 - 85微克/毫升。母乳中VPA水平为2.0 - 3.5微克/毫升,母乳中VPA与血液中VPA的比例为2 - 3%。这些结果表明VPA的胎盘转运率高而乳汁转运率低。

相似文献

1
Three cases of delivery under sodium valproate--placental transfer, milk transfer and probable teratogenicity of sodium valproate.三例丙戊酸钠治疗下的分娩——丙戊酸钠的胎盘转运、乳汁转运及可能的致畸性。
Jpn J Psychiatry Neurol. 1988 Mar;42(1):89-96. doi: 10.1111/j.1440-1819.1988.tb01960.x.
2
Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.丙戊酸及其代谢产物:胎盘转运、新生儿药代动力学、通过母乳的转运以及癫痫母亲新生儿的临床状况。
J Pharmacol Exp Ther. 1981 Dec;219(3):768-77.
3
Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.接受丙戊酸治疗的女性所生婴儿的胎儿生长、严重畸形和轻微异常情况。
J Pediatr. 1986 Jun;108(6):997-1004. doi: 10.1016/s0022-3476(86)80949-0.
4
Teratogenicity of sodium valproate.丙戊酸钠的致畸性。
Expert Opin Drug Saf. 2005 Mar;4(2):345-53. doi: 10.1517/14740338.4.2.345.
5
Fetal Valproate Syndrome.胎儿丙戊酸盐综合征
Pediatr Neonatol. 2017 Apr;58(2):158-164. doi: 10.1016/j.pedneo.2016.01.009. Epub 2016 Jun 17.
6
Concentration of valproate during pregnancy, in the newborn and in breast milk.
Acta Neurol Scand. 1985 Nov;72(5):460-3. doi: 10.1111/j.1600-0404.1985.tb00901.x.
7
Pregnancy after valproate withdrawal-Fetal malformations and seizure control.撤掉丙戊酸钠后的妊娠——胎儿畸形和癫痫控制。
Epilepsia. 2020 May;61(5):944-950. doi: 10.1111/epi.16505. Epub 2020 Apr 21.
8
Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status.妊娠和哺乳期癫痫女性使用乙琥胺。胎盘转运、哺乳婴儿的血清浓度及临床状况。
Br J Clin Pharmacol. 1984 Nov;18(5):671-7. doi: 10.1111/j.1365-2125.1984.tb02528.x.
9
[Influence of valproic acid (depakine I.V.) on human placenta metabolism--experimental model].[丙戊酸(德巴金静脉注射剂)对人胎盘代谢的影响——实验模型]
Ginekol Pol. 2003 Aug;74(8):596-602.
10
The management of epilepsy in women of child-bearing age and the Australian experience of valproate in pregnancy.
Clin Exp Neurol. 1987;23:145-8.

引用本文的文献

1
Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling-A Contribution from the ConcePTION Project.使用基于生理的药代动力学(PBPK)模型预测人乳中药物浓度的通用工作流程——来自ConcePTION项目的贡献。
Pharmaceutics. 2023 May 11;15(5):1469. doi: 10.3390/pharmaceutics15051469.
2
Transfer of anticonvulsants and lithium into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis.抗惊厥药物和锂在羊水中、脐血和母乳中的转移:系统评价和综合分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jun 8;124:110733. doi: 10.1016/j.pnpbp.2023.110733. Epub 2023 Feb 15.
3
Valproic Acid Concentrations in Mothers, Colostrum and Breastfed Infants during the Early Postpartum Period: Comparison with Concentrations Determined during Delivery and in the Mature Milk Period.
产后早期母亲、初乳和母乳喂养婴儿体内的丙戊酸浓度:与分娩时及成熟乳期所测定浓度的比较。
Pharmaceutics. 2021 Dec 3;13(12):2074. doi: 10.3390/pharmaceutics13122074.
4
[Use of antiepileptic drugs during breastfeeding : What do we tell the mother?].母乳喂养期间抗癫痫药物的使用:我们该如何告知母亲?
Nervenarzt. 2018 Aug;89(8):913-921. doi: 10.1007/s00115-018-0496-2.
5
Lactation studies of anticonvulsants: a quality review.抗惊厥药物的泌乳研究:质量综述。
Br J Clin Pharmacol. 2015 Apr;79(4):558-65. doi: 10.1111/bcp.12524.
6
Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.孕期情绪障碍的药物治疗:药代动力学变化综述及治疗药物监测的临床建议
J Clin Psychopharmacol. 2014 Apr;34(2):244-55. doi: 10.1097/JCP.0000000000000087.
7
Milk transfer and toxicokinetics of valproic Acid in lactating cynomolgus monkeys.哺乳期食蟹猴体内丙戊酸的乳汁转移及其毒代动力学。
Toxicol Res. 2013 Mar;29(1):53-60. doi: 10.5487/TR.2013.29.1.053.
8
Neonatal exposure to drugs in breast milk.新生儿通过母乳接触药物。
Pharm Res. 2004 Apr;21(4):555-66. doi: 10.1023/b:pham.0000022401.14710.c5.
9
Anticonvulsant use during lactation.
Drug Saf. 2000 Jun;22(6):425-40. doi: 10.2165/00002018-200022060-00002.